🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 12% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

4 Capsule(s) Serving Size
30 Servings
Other Combinations Product Type
12% Evidence Coverage

Supplement Facts — Evidence Check

📊 Market median: 340.0mg (243 products) 📚 3 studies — no high-quality reviews
This product: 500mg
CordycepsPrime(TM)
450 mg
N-Acetyl-Cysteine
400 mg
400 mg
📊 Market median: 250.0mg (562 products) 📚 53 studies (Tier A: 0, B: 19)
This product: 400mg
Chinese Skullcap Extract
300 mg
📊 Market median: 650.0mg (87 products) 📚 1 studies — no high-quality reviews
This product: 250mg
📊 Market median: 425.0mg (88 products)
Median 425.0mg This product: 250mg
Picrorhiza Extract
250 mg

Other Ingredients

Microcrystalline Cellulose Vegetable Stearate

Label Claims — Verification

All Other
All Other (98% of products) Structure/Function (86% of products) Nutrient (9% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free

Product Information

📋 Directions for Use

Recommended Use: As a dietary supplement, take four capsules per day, or as directed by your health care practitioner.

⚠️ Warnings & Precautions

KEEP OUT OF REACH OF CHILDREN.

🧪 Formulation Notes

Does not contain gluten.

Additional Information

HEP120

Notice: Color, size or shape may appear different between lots.

For Professional Use Only

Guaranteed GMP COMPLIANT Products

Manufactured in an NSF GMP Registered Facility

STORE IN A COOL, DRY PLACE.

Product Details

UPC / SKU 8 79452 00352 1
DSLD Entry Date 2013-07-25
Product Type Other Combinations
Form Capsule
DSLD ID 23543
Data Updated 2026-04-11

Research Evidence

6 Research Sources
60 Avg Quality Score
3 Meta Analysis
3 Rct
B Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors
Meta Analysis The Cochrane database of systematic reviews 2015
B Ganoderma lucidum (Reishi mushroom) for cancer treatment
Meta Analysis The Cochrane database of systematic reviews 2016
B Ganoderma lucidum (Reishi mushroom) for cancer treatment
Meta Analysis The Cochrane database of systematic reviews 2012
C Dynamic biomarkers indicate the immunological benefits provided by Ganoderma spore powder in post-operative breast and lung cancer patients
Rct Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2021
C Efficacy of Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Agaricomycetes) Supplementation on Psychological Stress and Selective Fitness Profile Parameters in Female College Students in West Bengal, India
Rct International journal of medicinal mushrooms 2024
C Preliminary Efficacy and Safety of Reishi & Privet Formula on Quality of Life Among Non-Small Cell Lung Cancer Patients Undergoing Chemotherapy: A Randomized Placebo-Controlled Trial
Rct Integrative cancer therapies 2020
View all evidence for Reishi →

Compare Similar Products

View all Reishi products →